Aiforia won the Vuoden Digiteko 2026 (Digital Innovation of the Year) award – AI enhances cancer diagnostics
recent articles
Nijmegen, The Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, has announced a collaboration with Physiogenex, a leading preclinical Contract...
From Aignostics GmbH: Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development, further strengthening Bayer’s precision oncology development portfolio ...
From Royal Philips: Cloud offering will help improve workflow integration, access, and reliability, delivering greater productivity and collaboration Collaboration combines best of clinical workflow leadership with scalable cloud...
Roche Diagnostics is at the forefront of diagnostic certainty, empowering oncology decision-making with our VENTANA portfolio. We help our customers improve and grow by offering a wide range of high-quality medical tests and digital...
ORNL: Artificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer. In partnership with the National Cancer Institute, or NCI, researchers from the Department of Energy’s Oak Ridge National...
From Diagnostics World: By Deborah Borfitz March 7, 2024 | Biomedical engineers have a significant role to play in the development and optimization of liquid biopsies to further precision oncology. Although molecular...
